Salicylic Acid

Description

No description information is available.

Uses and Indications

This drug is indicated for the removal of plantar warts located on the bottom of the foot. Plantar warts are characterized by their specific location, tenderness, and the disruption of the footprint pattern.

Limitations of Use: There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and if necessary, the wart may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely to ensure proper adhesion of the medicated patch.

If the size of the wart requires it, the medicated patches can be cut to fit the wart appropriately. The adhesive side of the patch should then be applied directly onto the wart. To ensure the patch remains in place and to conceal the treated area, it is recommended to cover the patch with pads.

This procedure should be repeated every 48 hours as needed, continuing until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use is contraindicated in the following situations:

Patients with diabetes or poor blood circulation should not use this product unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist, due to the increased risk of complications.

The product must not be applied to irritated, infected, or reddened skin, as this may exacerbate the condition.

Application is contraindicated on genital warts and warts located on the face to prevent potential adverse effects.

The product should not be used on moles, birthmarks, or warts with hair growing from them, as these may require different management.

Additionally, the product is contraindicated for use on mucous membranes, as it may cause irritation or other adverse reactions.

Warnings and Precautions

For external use only. This product is contraindicated in individuals who are diabetic or have poor blood circulation, unless used under the guidance and supervision of a qualified healthcare professional, such as a doctor or podiatrist.

The product should not be applied to irritated, infected, or reddened skin. It is also contraindicated for use on genital warts, warts located on the face, moles, birthmarks, and warts with hair growing from them. Additionally, the product must not be used on mucous membranes.

It is imperative to keep this and all medications out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be established without delay.

Healthcare professionals should advise patients to consult a doctor or podiatrist if discomfort persists following the use of this product. Regular monitoring and assessment may be necessary to ensure safe and effective use.

Side Effects

For external use only. Patients should not use this product if they are diabetic or have poor blood circulation, unless under the advice and supervision of a doctor or podiatrist. The product is contraindicated for application on irritated, infected, or reddened skin, as well as on genital warts, warts on the face, moles, birthmarks, and warts with hair growing from them. It should also not be applied to mucous membranes.

In the event that discomfort persists after use, patients are advised to consult their doctor or podiatrist for further evaluation and management.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (plantar wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this and all medications out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should be advised against the use of this product if they have diabetes or poor blood circulation, unless under the guidance and supervision of a healthcare professional, such as a doctor or podiatrist. The safety of this product during pregnancy has not been established, and its use is contraindicated on irritated, infected, or reddened skin. Additionally, it should not be applied to genital warts, facial warts, moles, birthmarks, or warts with hair growing from them. The product is also not intended for use on mucous membranes. Healthcare providers should carefully consider these factors when advising pregnant patients regarding the use of this product.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Consequently, healthcare professionals should exercise caution when considering this medication for lactating mothers, as the potential risks and benefits have not been established.

Breastfed infants may be affected by the absence of data on excretion in breast milk and the potential impact on their health. Therefore, it is advisable for healthcare providers to evaluate the necessity of this medication in lactating mothers on a case-by-case basis, taking into account the lack of specific information.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures should include supportive care and symptomatic treatment as necessary. Continuous evaluation of the patient's condition is recommended to address any complications that may arise.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this medication and all other drugs out of the reach of children. Instruct patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately.

It is important to inform patients that they should not use this medication if they are diabetic or have poor blood circulation, unless they are under the advice and supervision of a healthcare professional, such as a doctor or podiatrist. Additionally, patients should be cautioned against using the medication on irritated, infected, or reddened skin.

Patients must be made aware that this medication should not be applied to genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Furthermore, it should not be used on mucous membranes.

Finally, healthcare providers should encourage patients to consult their doctor or podiatrist if discomfort persists after using the medication.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within a temperature range of 59° to 86°F (15° to 30°C) to maintain its efficacy and stability. Proper storage conditions must be adhered to, ensuring that the product is kept in a suitable container that protects it from environmental factors. Special handling requirements should be observed to prevent any compromise to the product's integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)